A study has revealed that an anti-clotting drug effectively reduced bleeding events in individuals diagnosed with atrial fibrillation. The research highlights the potential of this medication in managing the risks associated with this common heart arrhythmia.
Study shows anti-clotting drug reduced bleeding events in patients with atrial fibrillation ." ScienceDaily. ScienceDaily, 23 January 2025. <www.sciencedaily.com
Wearable, long-term continuous heart monitors helped identify 52% more cases of atrial fibrillation compared to usual care, but that did not lead to a reduction in hospitalizations due to stroke, ... Atrial fibrillation is the most common cardiac arrhythmia worldwide with around 59 million people concerned in 2019. This irregular heartbeat is associated with increased risks of heart failure, ...
A study in more than 15,000 people has found that physical fitness is linked with a lower likelihood of developing atrial fibrillation and stroke. Atrial fibrillation is the most common heart rhythm ... While kidney function is known to be related to bleeding event risk, researchers conducted a post-hoc subgroup analysis of the Atrial Fibrillation and Ischemic Events with Rivaroxaban in Patients ...Fighting Experience Plays Key Role in Brain Chemical's Control of Male Aggression
Atrial Fibrillation Bleeding Events Anti-Clotting Drugs Cardiovascular Health Medical Research
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Rise in Alaska drug overdose deaths triggers increased effort to stop drug traffickingAccording to the Department of Law, as of Dec. 15, officers have seized over 317 pounds of drugs traveling through the airport including over 100 pounds of fentanyl.
Read more »
SF Supervisor Proposes Mass Arrests, 'Drug Jails' for Downtown Drug CrisisSan Francisco Supervisor Matt Dorsey calls for 'mass arrests' of drug users and dealers, aiming for at least 100 daily arrests, and proposes establishing 'drug jails' with medical and clinical interventions. Critics argue this approach is misguided and instead advocates for expanded behavioral health services.
Read more »
Eli Lilly's Zepbound Anti-Obesity Drug Poised to Drive Healthcare CostsEli Lilly & Co.'s weight-loss drug Zepbound is predicted to significantly impact healthcare costs for insurers, employers, and government programs. Already, GLP-1 drugs like Wegovy and Ozempic are major cost drivers, and Zepbound's superior efficacy and market expansion are expected to further increase expenses. Analysts project that Zepbound will dominate the obesity market, surpassing Novo Nordisk's Wegovy, leading to substantial increases in healthcare inflation.
Read more »
Religious Conservatives Trying to End Insurance Coverage of Incredibly Effective Anti-HIV DrugScience and Technology News and Videos
Read more »
Bishop confronts Trump on his anti-trans, anti-immigrant policies at Washington National CathederalThe Bishop of Washington, Rev. Mariann Edgar Budde, made a plea to President Donald Trump, who was in-person at an inaugural prayer service, to have “mercy” on Americans, particularly immigrants and LGBTQ people.
Read more »
Antibiotic After Sex Dramatically Reduces STI Risk, Study FindsA new study suggests that using a common antibiotic after sex can significantly lower the risk of contracting certain sexually transmitted infections (STIs). The study, conducted with patients at Kaiser Permanente Northern California, showed a dramatic decrease in chlamydia and gonorrhea rates among those who received doxycycline prophylaxis (doxyPEP).
Read more »